Insufficient scRNA-seq data for expression of FGF16 at single-cell level.
Insufficient scRNA-seq data for expression of FGF16 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 86% | 37.51 | 395 / 459 | 20% | 0.58 | 227 / 1118 |
| adipose | 89% | 40.97 | 1075 / 1204 | 0% | 0 | 0 / 0 |
| bladder | 86% | 31.10 | 18 / 21 | 2% | 0.02 | 8 / 504 |
| blood vessel | 76% | 14.91 | 1017 / 1335 | 0% | 0 | 0 / 0 |
| thymus | 60% | 8.34 | 390 / 653 | 2% | 0.04 | 12 / 605 |
| esophagus | 60% | 11.70 | 872 / 1445 | 1% | 0.01 | 1 / 183 |
| heart | 58% | 6.64 | 500 / 861 | 0% | 0 | 0 / 0 |
| muscle | 53% | 5.35 | 428 / 803 | 0% | 0 | 0 / 0 |
| intestine | 45% | 6.23 | 433 / 966 | 1% | 0.09 | 4 / 527 |
| skin | 36% | 4.17 | 650 / 1809 | 1% | 0.02 | 4 / 472 |
| brain | 32% | 3.17 | 850 / 2642 | 0% | 0.02 | 1 / 705 |
| uterus | 26% | 2.16 | 44 / 170 | 2% | 0.08 | 7 / 459 |
| kidney | 25% | 1.60 | 22 / 89 | 0% | 0.01 | 4 / 901 |
| lung | 21% | 2.41 | 122 / 578 | 2% | 0.03 | 18 / 1155 |
| stomach | 21% | 1.70 | 76 / 359 | 1% | 0.01 | 2 / 286 |
| adrenal gland | 7% | 0.46 | 18 / 258 | 9% | 1.19 | 21 / 230 |
| ovary | 12% | 1.52 | 22 / 180 | 4% | 0.10 | 16 / 430 |
| pancreas | 11% | 0.55 | 35 / 328 | 1% | 0.01 | 1 / 178 |
| prostate | 11% | 1.44 | 27 / 245 | 0% | 0 | 0 / 502 |
| peripheral blood | 6% | 0.59 | 57 / 929 | 0% | 0 | 0 / 0 |
| liver | 3% | 0.28 | 7 / 226 | 0% | 0 | 0 / 406 |
| spleen | 2% | 0.24 | 6 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_2000546 | Biological process | positive regulation of endothelial cell chemotaxis to fibroblast growth factor |
| GO_0009266 | Biological process | response to temperature stimulus |
| GO_0009887 | Biological process | animal organ morphogenesis |
| GO_0007165 | Biological process | signal transduction |
| GO_0010628 | Biological process | positive regulation of gene expression |
| GO_1903670 | Biological process | regulation of sprouting angiogenesis |
| GO_0001934 | Biological process | positive regulation of protein phosphorylation |
| GO_0043410 | Biological process | positive regulation of MAPK cascade |
| GO_0007267 | Biological process | cell-cell signaling |
| GO_0043405 | Biological process | regulation of MAP kinase activity |
| GO_0030154 | Biological process | cell differentiation |
| GO_0030334 | Biological process | regulation of cell migration |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0001936 | Biological process | regulation of endothelial cell proliferation |
| GO_0008543 | Biological process | fibroblast growth factor receptor signaling pathway |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0008083 | Molecular function | growth factor activity |
| GO_0005104 | Molecular function | fibroblast growth factor receptor binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FGF16 |
| Protein name | Fibroblast growth factor 16 (FGF-16) |
| Synonyms | |
| Description | FUNCTION: Plays an important role in the regulation of embryonic development, cell proliferation and cell differentiation, and is required for normal cardiomyocyte proliferation and heart development. . |
| Accessions | ENST00000439435.3 O43320 |